TY - JOUR
T1 - Circular RNA regulatory role in pathological cardiac remodelling
AU - Bibi, Alessia
AU - Bartekova, Monika
AU - Gandhi, Shrey
AU - Greco, Simona
AU - Madè, Alisia
AU - Sarkar, Moumita
AU - Stopa, Victoria
AU - Tastsoglou, Spyros
AU - de Gonzalo-Calvo, David
AU - Devaux, Yvan
AU - Emanueli, Costanza
AU - Hatzigeorgiou, Artemis G.
AU - Nossent, A. Yaël
AU - Zhou, Zhichao
AU - Martelli, Fabio
N1 - Grants and funding
APVV-21-0194/Slovak Research and Development Agency
VEGA 2/0159/24/Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences
281125614/Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
CH/15/1/31199/British Heart Foundation (BHF) Chair Award
RG/20/9/35101/BHF Programme Grant
© 2024 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
PY - 2024/6/3
Y1 - 2024/6/3
N2 - Cardiac remodelling involves structural, cellular and molecular alterations in the heart after injury, resulting in progressive loss of heart function and ultimately leading to heart failure. Circular RNAs (circRNAs) are a recently rediscovered class of non-coding RNAs that play regulatory roles in the pathogenesis of cardiovascular diseases, including heart failure. Thus, a more comprehensive understanding of the role of circRNAs in the processes governing cardiac remodelling may set the ground for the development of circRNA-based diagnostic and therapeutic strategies. In this review, the current knowledge about circRNA origin, conservation, characteristics and function is summarized. Bioinformatics and wet-lab methods used in circRNA research are discussed. The regulatory function of circRNAs in cardiac remodelling mechanisms such as cell death, cardiomyocyte hypertrophy, inflammation, fibrosis and metabolism is highlighted. Finally, key challenges and opportunities in circRNA research are discussed, and orientations for future work to address the pharmacological potential of circRNAs in heart failure are proposed.
AB - Cardiac remodelling involves structural, cellular and molecular alterations in the heart after injury, resulting in progressive loss of heart function and ultimately leading to heart failure. Circular RNAs (circRNAs) are a recently rediscovered class of non-coding RNAs that play regulatory roles in the pathogenesis of cardiovascular diseases, including heart failure. Thus, a more comprehensive understanding of the role of circRNAs in the processes governing cardiac remodelling may set the ground for the development of circRNA-based diagnostic and therapeutic strategies. In this review, the current knowledge about circRNA origin, conservation, characteristics and function is summarized. Bioinformatics and wet-lab methods used in circRNA research are discussed. The regulatory function of circRNAs in cardiac remodelling mechanisms such as cell death, cardiomyocyte hypertrophy, inflammation, fibrosis and metabolism is highlighted. Finally, key challenges and opportunities in circRNA research are discussed, and orientations for future work to address the pharmacological potential of circRNAs in heart failure are proposed.
KW - biomarkers
KW - cardiac remodelling
KW - circular RNAs
KW - heart failure
KW - therapeutic potential
UR - http://www.scopus.com/inward/record.url?scp=85195166599&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/38830749
U2 - 10.1111/bph.16434
DO - 10.1111/bph.16434
M3 - Review article
C2 - 38830749
SN - 0007-1188
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
ER -